国际肝胆胰疾病杂志（英文版）2020，Vol.19Issue(2)：184-186,3.
Composite hepatocellular and hemangiosarcomatous tumor: The prognosis is determined by the sarcomatous component
Composite hepatocellular and hemangiosarcomatous tumor: The prognosis is determined by the sarcomatous component
Giuseppe Orlando 1Quirino Lai 2Jan Lerut3
作者信息
- 1. Department of General Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, USA
- 2. Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
- 3. Starzl Unit of Abdominal Transplantation,Pôle de Chirurgie Expérimentale et Transplantation, Institute of Experimental and Clinical Research [IREC], Université catholique de Louvain, Brussels, Belgium
- 折叠
引用本文复制引用
Giuseppe Orlando,Quirino Lai,Jan Lerut..Composite hepatocellular and hemangiosarcomatous tumor: The prognosis is determined by the sarcomatous component[J].国际肝胆胰疾病杂志（英文版）,2020,19(2):184-186,3.
